Psoriatic Arthritis (PsA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
This reports provides a data-driven overview of the current and future competitive landscape in PsA therapeutics. • There will be more than 6 million prevalent cases of PsA in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast. • There are 14 leading marketed drugs for the treatment of PsA, Janssen is the key player in the PsA landscape with five marketed products. • R&D activity in PsA is robust globally, with three products in the pre-registration phase in...
Ankylosing Spondylitis (Bekhterev’s Disease) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Ankylosing Spondylitis Clinical Trials Market Report Overview The Ankylosing Spondylitis clinical trial market research report provides an overview of Ankylosing Spondylitis clinical trials scenario. The report provides top-line data relating to the clinical trials on Ankylosing Spondylitis. It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type. Key...
Osteoarthritis Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021 – 2031
The osteoarthritis (OA) market size was valued at $2.5 billion in 2021 and is expected to achieve a CAGR of more than 4% during 2021-2031. OA is a slowly progressive joint disease characterized by degradation of the articular (hyaline) cartilage that coats the bone proximities of synovial joints. Contrary to the previous notion that OA is exclusively a disorder of articular cartilage, studies have demonstrated it is a disease of the whole joint, adversely affecting the subchondral bone, tendons, ligaments,...
Osteoarthritis Epidemiology Analysis and Forecast, 2021-2031
Osteoarthritis (OA) market size was 18,820,737 cases in 2021 cases across 7MM. The market is expected to grow at an AGR of more than 1% during the forecast period. The osteoarthritis epidemiology market research report provides an overview of the risk factors, comorbidities, and global and historical trends for hand OA, knee OA, and hip OA in the seven major markets or 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the total...